24/03/2021
Strong growth of the medical business. Resilience of the Group in the context of global pandemic.... more
27/01/2021
Operating profit at +0.1 million euros in Q4 20. Quarterly sales of the medical business multiplied by 2.9 compared to Q4 2019. . Positive quarterly EBITDA at +0.3 million euros / Positive cumulative 12-month EBITDA at +0.8 million euros. Available liquidities at 4.2 million euros on 31 December 2020.... more
26/10/2020
Significant growth in the medical business partially offsetting the impact of the Covid-19 pandemic on the Group's avionics business. Favourable evolution of the optical communications business over the quarter. Positive quarterly EBITDA / Cumulative 9-month EBITDA exceeding 0.5 million euros. Increase in net cash of +0.1 million euros over Q3 2020 and +1.0 million euros over the first 9 months of the year. Available liquidities at 4.2 million euros at 30 September 2020.... more
31/08/2020
Impact of the Covid-19 pandemic on the Group's avionics business fully offset by the significant growth of the medical business. Optical communications business impacted by the Covid-19 pandemic and the related closure of the US production site for more than two weeks. Half-year operating loss limited to 0.1 million euros.... more
28/07/2020
Impact of the Covid-19 pandemic on the Group's avionics business fully offset by the significant growth of the medical business. Optical communications business impacted by the Covid-19 pandemic and the related closure of the US production site for more than two weeks. Half-year operating loss and Q2 operating loss limited to 0.1 million euros. Half-year EBITDA at 0.5 million euros and Q2 EBITDA at 0.2 million euros despite an unprecedented macroeconomic environment. Increase of available liquidities up to EUR 4.2 million at 30 June 2020.... more
European Headquarters:
MEMSCAP S.A.
Parc Activillage des Fontaines
ZI Bernin
38 926 Crolles Cedex
France
Phone : +33 (0)4 76 92 85 00
Fax : +33 (0)4 76 92 85 01
Access map: click here
upcoming events: